Himadri Speciality Chemical enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
27,054————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
119290159216208
53.255.449.2−2.8−2.8
767767309600836
27,754————
647477149385628
₹550.13————
5,9555,5294,0803,6433,114
12.9%13.9%7.6%16.5%26.9%
0.03×————
4.96×————
25.53×————
27.53×————
Reference items — trailing FY values
5,5954,6614,6134,1854,172
1,087962854645399
1,008894799595348
—38244740554.0
−67.7−67.7276352−29.2
—−84.2263334−40.3
—45017152.883.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HSCL₹536.25

Himadri Speciality Chemical Ltd.

· Chemicals
₹ CrorePeersPCBLGRAPHITEHEGNOCILROSSARINAVINFLUORTATACHEMDDEVPLSTIKMcap ₹27,054 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————27,053.8
- Cash, Equiv & ST Investments207.8215.7159.3289.5119.4
+ Minority Interest-2.8-2.849.255.453.2
+ Total Debt836.2600.4308.7766.6766.6
Enterprise Value————27,754.2
Net Debt (memo)628.4384.7149.4477.0647.2
EV per Share————550.13
Total Capital3,113.93,643.24,079.75,528.65,955.0
Total Debt/Total Capital26.8516.487.5713.8712.87
Total Debt/EV————0.03
EV/Sales————4.96
EV/EBITDA————25.53
EV/EBIT————27.53
Reference Items — Trailing FY Values
Sales4,171.84,184.94,612.64,660.75,594.7
EBITDA399.2645.1854.2962.11,087.2
EBIT348.4595.2799.3894.01,008.1
Operating Cash Flow54.0404.8446.9382.0—
Free Cash Flow-29.2352.0276.0-67.7-67.7
FCFF (free cash flow to the firm)-40.3334.1263.0-84.2—
Capital Expenditure83.252.8170.9449.7—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.